Global Flupentixol Market Growth 2026-2032
The global Flupentixol market size is predicted to grow from US$ 326 million in 2025 to US$ 449 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
In 2025, global flupentixol production reached 53 metric tons, with an estimated average selling price of $6,280 per kilogram. Flupentixol is a typical thioxanthene antipsychotic that exerts its effects primarily through dopamine receptor antagonism. Clinical product forms include oral flupentixol dihydrochloride/hydrochloride, long-acting injectable flupentixol decanoate, and a low-dose combination formulation of flupentixol and melitracen used for the maintenance treatment of chronic schizophrenia. The upstream supply chain primarily comprises thioxanthene intermediates, fluorinated aromatic intermediates, piperazine intermediates, decanoate esterification reagents, solvents, catalysts, pharmaceutical excipients, packaging materials (ampoules, vials, tablet packaging), and GMP production and quality testing services. The midstream sector involves API synthesis, salt/ester conversion, formulation development, tablet compression, sterile or oil-based injection filling, regulatory filing, and drug release. The downstream sector mainly consists of psychiatric hospitals, psychiatric/psychological departments in general hospitals, pharmaceutical wholesalers, retail pharmacies, and patient populations requiring maintenance therapy for chronic conditions. Gross profit margin ranges from approximately 30% to 50%.
Regarding regional distribution, there is significant demand for combination products and generics in the Asia-Pacific region (specifically China and India); Europe accounts for a substantial share of the market for originator brands, long-acting injections, and established psychiatric prescriptions; while the North American market?specifically Canada?remains limited. Looking ahead, as an established drug, flupentixol?s growth will be driven primarily by rising rates of mental health diagnosis and treatment, the demand for maintenance therapy via long-acting injections, API supply capabilities in India and China, the accessibility of low-cost generics, and existing demand for combination products in certain Asian markets.
LP Information, Inc. (LPI) ' newest research report, the ?Flupentixol Industry Forecast? looks at past sales and reviews total world Flupentixol sales in 2025, providing a comprehensive analysis by region and market sector of projected Flupentixol sales for 2026 through 2032. With Flupentixol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flupentixol industry.
This Insight Report provides a comprehensive analysis of the global Flupentixol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flupentixol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Flupentixol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flupentixol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flupentixol.
This report presents a comprehensive overview, market shares, and growth opportunities of Flupentixol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Flupentixol market?
What factors are driving Flupentixol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flupentixol market opportunities vary by end market size?
How does Flupentixol break out by Type, by Application?
In 2025, global flupentixol production reached 53 metric tons, with an estimated average selling price of $6,280 per kilogram. Flupentixol is a typical thioxanthene antipsychotic that exerts its effects primarily through dopamine receptor antagonism. Clinical product forms include oral flupentixol dihydrochloride/hydrochloride, long-acting injectable flupentixol decanoate, and a low-dose combination formulation of flupentixol and melitracen used for the maintenance treatment of chronic schizophrenia. The upstream supply chain primarily comprises thioxanthene intermediates, fluorinated aromatic intermediates, piperazine intermediates, decanoate esterification reagents, solvents, catalysts, pharmaceutical excipients, packaging materials (ampoules, vials, tablet packaging), and GMP production and quality testing services. The midstream sector involves API synthesis, salt/ester conversion, formulation development, tablet compression, sterile or oil-based injection filling, regulatory filing, and drug release. The downstream sector mainly consists of psychiatric hospitals, psychiatric/psychological departments in general hospitals, pharmaceutical wholesalers, retail pharmacies, and patient populations requiring maintenance therapy for chronic conditions. Gross profit margin ranges from approximately 30% to 50%.
Regarding regional distribution, there is significant demand for combination products and generics in the Asia-Pacific region (specifically China and India); Europe accounts for a substantial share of the market for originator brands, long-acting injections, and established psychiatric prescriptions; while the North American market?specifically Canada?remains limited. Looking ahead, as an established drug, flupentixol?s growth will be driven primarily by rising rates of mental health diagnosis and treatment, the demand for maintenance therapy via long-acting injections, API supply capabilities in India and China, the accessibility of low-cost generics, and existing demand for combination products in certain Asian markets.
LP Information, Inc. (LPI) ' newest research report, the ?Flupentixol Industry Forecast? looks at past sales and reviews total world Flupentixol sales in 2025, providing a comprehensive analysis by region and market sector of projected Flupentixol sales for 2026 through 2032. With Flupentixol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flupentixol industry.
This Insight Report provides a comprehensive analysis of the global Flupentixol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flupentixol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Flupentixol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flupentixol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flupentixol.
This report presents a comprehensive overview, market shares, and growth opportunities of Flupentixol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- API (Active Pharmaceutical Ingredient)
- Tablet
- Drops/Oral Solution
- Long-Acting Intramuscular Injection
- Flupentixol Base
- Flupentixol Dihydrochloride
- Flupentixol Decanoate
- Schizophrenia
- Chronic Psychosis
- Anxiety/Depression
- Regional/Localized Psychosis
- Hospital Psychiatric Department
- Specialist Clinic
- Retail Pharmacie
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lundbeck
- Sandoz Canada
- Global Calcium
- Centaur Pharmaceuticals
- Pharmaffiliates
- Sun Pharma
- Haisco Pharmaceutical Group
- Chongqing Shenghuaxi Pharmaceutical
- Brilliant Pharmaceuticals
- Guangzhou Green Cross Pharmaceutical
- China Medical System
What is the 10-year outlook for the global Flupentixol market?
What factors are driving Flupentixol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Flupentixol market opportunities vary by end market size?
How does Flupentixol break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Flupentixol Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Flupentixol by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Flupentixol by Country/Region, 2021, 2025 & 2032
2.2 Flupentixol Segment by Type
2.2.1 API (Active Pharmaceutical Ingredient)
2.2.2 Tablet
2.2.3 Drops/Oral Solution
2.2.4 Long-Acting Intramuscular Injection
2.2.5 Flupentixol Sales by Type
2.2.5.1 Global Flupentixol Sales Market Share by Type (2021-2026)
2.2.5.2 Global Flupentixol Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Flupentixol Sale Price by Type (2021-2026)
2.3 Flupentixol Segment by Chemical Form
2.3.1 Flupentixol Base
2.3.2 Flupentixol Dihydrochloride
2.3.3 Flupentixol Decanoate
2.3.4 Flupentixol Sales by Chemical Form
2.3.4.1 Global Flupentixol Sales Market Share by Chemical Form (2021-2026)
2.3.4.2 Global Flupentixol Revenue and Market Share by Chemical Form (2021-2026)
2.3.4.3 Global Flupentixol Sale Price by Chemical Form (2021-2026)
2.4 Flupentixol Segment by Target Condition
2.4.1 Schizophrenia
2.4.2 Chronic Psychosis
2.4.3 Anxiety/Depression
2.4.4 Regional/Localized Psychosis
2.4.5 Flupentixol Sales by Target Condition
2.4.5.1 Global Flupentixol Sales Market Share by Target Condition (2021-2026)
2.4.5.2 Global Flupentixol Revenue and Market Share by Target Condition (2021-2026)
2.4.5.3 Global Flupentixol Sale Price by Target Condition (2021-2026)
2.5 Flupentixol Segment by Application
2.5.1 Hospital Psychiatric Department
2.5.2 Specialist Clinic
2.5.3 Retail Pharmacie
2.5.4 Others
2.5.5 Flupentixol Sales by Application
2.5.5.1 Global Flupentixol Sale Market Share by Application (2021-2026)
2.5.5.2 Global Flupentixol Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Flupentixol Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Flupentixol Breakdown Data by Company
3.1.1 Global Flupentixol Annual Sales by Company (2021-2026)
3.1.2 Global Flupentixol Sales Market Share by Company (2021-2026)
3.2 Global Flupentixol Annual Revenue by Company (2021-2026)
3.2.1 Global Flupentixol Revenue by Company (2021-2026)
3.2.2 Global Flupentixol Revenue Market Share by Company (2021-2026)
3.3 Global Flupentixol Sale Price by Company
3.4 Key Manufacturers Flupentixol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flupentixol Product Location Distribution
3.4.2 Players Flupentixol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FLUPENTIXOL BY GEOGRAPHIC REGION
4.1 World Historic Flupentixol Market Size by Geographic Region (2021-2026)
4.1.1 Global Flupentixol Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Flupentixol Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Flupentixol Market Size by Country/Region (2021-2026)
4.2.1 Global Flupentixol Annual Sales by Country/Region (2021-2026)
4.2.2 Global Flupentixol Annual Revenue by Country/Region (2021-2026)
4.3 Americas Flupentixol Sales Growth
4.4 APAC Flupentixol Sales Growth
4.5 Europe Flupentixol Sales Growth
4.6 Middle East & Africa Flupentixol Sales Growth
5 AMERICAS
5.1 Americas Flupentixol Sales by Country
5.1.1 Americas Flupentixol Sales by Country (2021-2026)
5.1.2 Americas Flupentixol Revenue by Country (2021-2026)
5.2 Americas Flupentixol Sales by Type (2021-2026)
5.3 Americas Flupentixol Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flupentixol Sales by Region
6.1.1 APAC Flupentixol Sales by Region (2021-2026)
6.1.2 APAC Flupentixol Revenue by Region (2021-2026)
6.2 APAC Flupentixol Sales by Type (2021-2026)
6.3 APAC Flupentixol Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Flupentixol by Country
7.1.1 Europe Flupentixol Sales by Country (2021-2026)
7.1.2 Europe Flupentixol Revenue by Country (2021-2026)
7.2 Europe Flupentixol Sales by Type (2021-2026)
7.3 Europe Flupentixol Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Flupentixol by Country
8.1.1 Middle East & Africa Flupentixol Sales by Country (2021-2026)
8.1.2 Middle East & Africa Flupentixol Revenue by Country (2021-2026)
8.2 Middle East & Africa Flupentixol Sales by Type (2021-2026)
8.3 Middle East & Africa Flupentixol Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flupentixol
10.3 Manufacturing Process Analysis of Flupentixol
10.4 Industry Chain Structure of Flupentixol
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flupentixol Distributors
11.3 Flupentixol Customer
12 WORLD FORECAST REVIEW FOR FLUPENTIXOL BY GEOGRAPHIC REGION
12.1 Global Flupentixol Market Size Forecast by Region
12.1.1 Global Flupentixol Forecast by Region (2027-2032)
12.1.2 Global Flupentixol Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Flupentixol Forecast by Type (2027-2032)
12.7 Global Flupentixol Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lundbeck
13.1.1 Lundbeck Company Information
13.1.2 Lundbeck Flupentixol Product Portfolios and Specifications
13.1.3 Lundbeck Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lundbeck Main Business Overview
13.1.5 Lundbeck Latest Developments
13.2 Sandoz Canada
13.2.1 Sandoz Canada Company Information
13.2.2 Sandoz Canada Flupentixol Product Portfolios and Specifications
13.2.3 Sandoz Canada Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Canada Main Business Overview
13.2.5 Sandoz Canada Latest Developments
13.3 Global Calcium
13.3.1 Global Calcium Company Information
13.3.2 Global Calcium Flupentixol Product Portfolios and Specifications
13.3.3 Global Calcium Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Global Calcium Main Business Overview
13.3.5 Global Calcium Latest Developments
13.4 Centaur Pharmaceuticals
13.4.1 Centaur Pharmaceuticals Company Information
13.4.2 Centaur Pharmaceuticals Flupentixol Product Portfolios and Specifications
13.4.3 Centaur Pharmaceuticals Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Centaur Pharmaceuticals Main Business Overview
13.4.5 Centaur Pharmaceuticals Latest Developments
13.5 Pharmaffiliates
13.5.1 Pharmaffiliates Company Information
13.5.2 Pharmaffiliates Flupentixol Product Portfolios and Specifications
13.5.3 Pharmaffiliates Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pharmaffiliates Main Business Overview
13.5.5 Pharmaffiliates Latest Developments
13.6 Sun Pharma
13.6.1 Sun Pharma Company Information
13.6.2 Sun Pharma Flupentixol Product Portfolios and Specifications
13.6.3 Sun Pharma Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharma Main Business Overview
13.6.5 Sun Pharma Latest Developments
13.7 Haisco Pharmaceutical Group
13.7.1 Haisco Pharmaceutical Group Company Information
13.7.2 Haisco Pharmaceutical Group Flupentixol Product Portfolios and Specifications
13.7.3 Haisco Pharmaceutical Group Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Haisco Pharmaceutical Group Main Business Overview
13.7.5 Haisco Pharmaceutical Group Latest Developments
13.8 Chongqing Shenghuaxi Pharmaceutical
13.8.1 Chongqing Shenghuaxi Pharmaceutical Company Information
13.8.2 Chongqing Shenghuaxi Pharmaceutical Flupentixol Product Portfolios and Specifications
13.8.3 Chongqing Shenghuaxi Pharmaceutical Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chongqing Shenghuaxi Pharmaceutical Main Business Overview
13.8.5 Chongqing Shenghuaxi Pharmaceutical Latest Developments
13.9 Brilliant Pharmaceuticals
13.9.1 Brilliant Pharmaceuticals Company Information
13.9.2 Brilliant Pharmaceuticals Flupentixol Product Portfolios and Specifications
13.9.3 Brilliant Pharmaceuticals Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Brilliant Pharmaceuticals Main Business Overview
13.9.5 Brilliant Pharmaceuticals Latest Developments
13.10 Guangzhou Green Cross Pharmaceutical
13.10.1 Guangzhou Green Cross Pharmaceutical Company Information
13.10.2 Guangzhou Green Cross Pharmaceutical Flupentixol Product Portfolios and Specifications
13.10.3 Guangzhou Green Cross Pharmaceutical Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Guangzhou Green Cross Pharmaceutical Main Business Overview
13.10.5 Guangzhou Green Cross Pharmaceutical Latest Developments
13.11 China Medical System
13.11.1 China Medical System Company Information
13.11.2 China Medical System Flupentixol Product Portfolios and Specifications
13.11.3 China Medical System Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 China Medical System Main Business Overview
13.11.5 China Medical System Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Flupentixol Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Flupentixol by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Flupentixol by Country/Region, 2021, 2025 & 2032
2.2 Flupentixol Segment by Type
2.2.1 API (Active Pharmaceutical Ingredient)
2.2.2 Tablet
2.2.3 Drops/Oral Solution
2.2.4 Long-Acting Intramuscular Injection
2.2.5 Flupentixol Sales by Type
2.2.5.1 Global Flupentixol Sales Market Share by Type (2021-2026)
2.2.5.2 Global Flupentixol Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Flupentixol Sale Price by Type (2021-2026)
2.3 Flupentixol Segment by Chemical Form
2.3.1 Flupentixol Base
2.3.2 Flupentixol Dihydrochloride
2.3.3 Flupentixol Decanoate
2.3.4 Flupentixol Sales by Chemical Form
2.3.4.1 Global Flupentixol Sales Market Share by Chemical Form (2021-2026)
2.3.4.2 Global Flupentixol Revenue and Market Share by Chemical Form (2021-2026)
2.3.4.3 Global Flupentixol Sale Price by Chemical Form (2021-2026)
2.4 Flupentixol Segment by Target Condition
2.4.1 Schizophrenia
2.4.2 Chronic Psychosis
2.4.3 Anxiety/Depression
2.4.4 Regional/Localized Psychosis
2.4.5 Flupentixol Sales by Target Condition
2.4.5.1 Global Flupentixol Sales Market Share by Target Condition (2021-2026)
2.4.5.2 Global Flupentixol Revenue and Market Share by Target Condition (2021-2026)
2.4.5.3 Global Flupentixol Sale Price by Target Condition (2021-2026)
2.5 Flupentixol Segment by Application
2.5.1 Hospital Psychiatric Department
2.5.2 Specialist Clinic
2.5.3 Retail Pharmacie
2.5.4 Others
2.5.5 Flupentixol Sales by Application
2.5.5.1 Global Flupentixol Sale Market Share by Application (2021-2026)
2.5.5.2 Global Flupentixol Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Flupentixol Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Flupentixol Breakdown Data by Company
3.1.1 Global Flupentixol Annual Sales by Company (2021-2026)
3.1.2 Global Flupentixol Sales Market Share by Company (2021-2026)
3.2 Global Flupentixol Annual Revenue by Company (2021-2026)
3.2.1 Global Flupentixol Revenue by Company (2021-2026)
3.2.2 Global Flupentixol Revenue Market Share by Company (2021-2026)
3.3 Global Flupentixol Sale Price by Company
3.4 Key Manufacturers Flupentixol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flupentixol Product Location Distribution
3.4.2 Players Flupentixol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FLUPENTIXOL BY GEOGRAPHIC REGION
4.1 World Historic Flupentixol Market Size by Geographic Region (2021-2026)
4.1.1 Global Flupentixol Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Flupentixol Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Flupentixol Market Size by Country/Region (2021-2026)
4.2.1 Global Flupentixol Annual Sales by Country/Region (2021-2026)
4.2.2 Global Flupentixol Annual Revenue by Country/Region (2021-2026)
4.3 Americas Flupentixol Sales Growth
4.4 APAC Flupentixol Sales Growth
4.5 Europe Flupentixol Sales Growth
4.6 Middle East & Africa Flupentixol Sales Growth
5 AMERICAS
5.1 Americas Flupentixol Sales by Country
5.1.1 Americas Flupentixol Sales by Country (2021-2026)
5.1.2 Americas Flupentixol Revenue by Country (2021-2026)
5.2 Americas Flupentixol Sales by Type (2021-2026)
5.3 Americas Flupentixol Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flupentixol Sales by Region
6.1.1 APAC Flupentixol Sales by Region (2021-2026)
6.1.2 APAC Flupentixol Revenue by Region (2021-2026)
6.2 APAC Flupentixol Sales by Type (2021-2026)
6.3 APAC Flupentixol Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Flupentixol by Country
7.1.1 Europe Flupentixol Sales by Country (2021-2026)
7.1.2 Europe Flupentixol Revenue by Country (2021-2026)
7.2 Europe Flupentixol Sales by Type (2021-2026)
7.3 Europe Flupentixol Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Flupentixol by Country
8.1.1 Middle East & Africa Flupentixol Sales by Country (2021-2026)
8.1.2 Middle East & Africa Flupentixol Revenue by Country (2021-2026)
8.2 Middle East & Africa Flupentixol Sales by Type (2021-2026)
8.3 Middle East & Africa Flupentixol Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flupentixol
10.3 Manufacturing Process Analysis of Flupentixol
10.4 Industry Chain Structure of Flupentixol
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flupentixol Distributors
11.3 Flupentixol Customer
12 WORLD FORECAST REVIEW FOR FLUPENTIXOL BY GEOGRAPHIC REGION
12.1 Global Flupentixol Market Size Forecast by Region
12.1.1 Global Flupentixol Forecast by Region (2027-2032)
12.1.2 Global Flupentixol Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Flupentixol Forecast by Type (2027-2032)
12.7 Global Flupentixol Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lundbeck
13.1.1 Lundbeck Company Information
13.1.2 Lundbeck Flupentixol Product Portfolios and Specifications
13.1.3 Lundbeck Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lundbeck Main Business Overview
13.1.5 Lundbeck Latest Developments
13.2 Sandoz Canada
13.2.1 Sandoz Canada Company Information
13.2.2 Sandoz Canada Flupentixol Product Portfolios and Specifications
13.2.3 Sandoz Canada Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Canada Main Business Overview
13.2.5 Sandoz Canada Latest Developments
13.3 Global Calcium
13.3.1 Global Calcium Company Information
13.3.2 Global Calcium Flupentixol Product Portfolios and Specifications
13.3.3 Global Calcium Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Global Calcium Main Business Overview
13.3.5 Global Calcium Latest Developments
13.4 Centaur Pharmaceuticals
13.4.1 Centaur Pharmaceuticals Company Information
13.4.2 Centaur Pharmaceuticals Flupentixol Product Portfolios and Specifications
13.4.3 Centaur Pharmaceuticals Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Centaur Pharmaceuticals Main Business Overview
13.4.5 Centaur Pharmaceuticals Latest Developments
13.5 Pharmaffiliates
13.5.1 Pharmaffiliates Company Information
13.5.2 Pharmaffiliates Flupentixol Product Portfolios and Specifications
13.5.3 Pharmaffiliates Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pharmaffiliates Main Business Overview
13.5.5 Pharmaffiliates Latest Developments
13.6 Sun Pharma
13.6.1 Sun Pharma Company Information
13.6.2 Sun Pharma Flupentixol Product Portfolios and Specifications
13.6.3 Sun Pharma Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharma Main Business Overview
13.6.5 Sun Pharma Latest Developments
13.7 Haisco Pharmaceutical Group
13.7.1 Haisco Pharmaceutical Group Company Information
13.7.2 Haisco Pharmaceutical Group Flupentixol Product Portfolios and Specifications
13.7.3 Haisco Pharmaceutical Group Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Haisco Pharmaceutical Group Main Business Overview
13.7.5 Haisco Pharmaceutical Group Latest Developments
13.8 Chongqing Shenghuaxi Pharmaceutical
13.8.1 Chongqing Shenghuaxi Pharmaceutical Company Information
13.8.2 Chongqing Shenghuaxi Pharmaceutical Flupentixol Product Portfolios and Specifications
13.8.3 Chongqing Shenghuaxi Pharmaceutical Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chongqing Shenghuaxi Pharmaceutical Main Business Overview
13.8.5 Chongqing Shenghuaxi Pharmaceutical Latest Developments
13.9 Brilliant Pharmaceuticals
13.9.1 Brilliant Pharmaceuticals Company Information
13.9.2 Brilliant Pharmaceuticals Flupentixol Product Portfolios and Specifications
13.9.3 Brilliant Pharmaceuticals Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Brilliant Pharmaceuticals Main Business Overview
13.9.5 Brilliant Pharmaceuticals Latest Developments
13.10 Guangzhou Green Cross Pharmaceutical
13.10.1 Guangzhou Green Cross Pharmaceutical Company Information
13.10.2 Guangzhou Green Cross Pharmaceutical Flupentixol Product Portfolios and Specifications
13.10.3 Guangzhou Green Cross Pharmaceutical Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Guangzhou Green Cross Pharmaceutical Main Business Overview
13.10.5 Guangzhou Green Cross Pharmaceutical Latest Developments
13.11 China Medical System
13.11.1 China Medical System Company Information
13.11.2 China Medical System Flupentixol Product Portfolios and Specifications
13.11.3 China Medical System Flupentixol Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 China Medical System Main Business Overview
13.11.5 China Medical System Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Flupentixol Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Flupentixol Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of API (Active Pharmaceutical Ingredient)
Table 4. Major Players ofTablet
Table 5. Major Players of Drops/Oral Solution
Table 6. Major Players of Long-Acting Intramuscular Injection
Table 7. Global Flupentixol Sales by Type (2021-2026) & (Ton)
Table 8. Global Flupentixol Sales Market Share by Type (2021-2026)
Table 9. Global Flupentixol Revenue by Type (2021-2026) & ($ million)
Table 10. Global Flupentixol Revenue Market Share by Type (2021-2026)
Table 11. Global Flupentixol Sale Price by Type (2021-2026) & (US$/kg)
Table 12. Major Players of Flupentixol Base
Table 13. Major Players of Flupentixol Dihydrochloride
Table 14. Major Players of Flupentixol Decanoate
Table 15. Global Flupentixol Sales by Chemical Form (2021-2026) & (Ton)
Table 16. Global Flupentixol Sales Market Share by Chemical Form (2021-2026)
Table 17. Global Flupentixol Revenue by Chemical Form (2021-2026) & ($ million)
Table 18. Global Flupentixol Revenue Market Share by Chemical Form (2021-2026)
Table 19. Global Flupentixol Sale Price by Chemical Form (2021-2026) & (US$/kg)
Table 20. Major Players of Schizophrenia
Table 21. Major Players of Chronic Psychosis
Table 22. Major Players of Anxiety/Depression
Table 23. Major Players of Regional/Localized Psychosis
Table 24. Global Flupentixol Sales by Target Condition (2021-2026) & (Ton)
Table 25. Global Flupentixol Sales Market Share by Target Condition (2021-2026)
Table 26. Global Flupentixol Revenue by Target Condition (2021-2026) & ($ million)
Table 27. Global Flupentixol Revenue Market Share by Target Condition (2021-2026)
Table 28. Global Flupentixol Sale Price by Target Condition (2021-2026) & (US$/kg)
Table 29. Global Flupentixol Sale by Application (2021-2026) & (Ton)
Table 30. Global Flupentixol Sale Market Share by Application (2021-2026)
Table 31. Global Flupentixol Revenue by Application (2021-2026) & ($ million)
Table 32. Global Flupentixol Revenue Market Share by Application (2021-2026)
Table 33. Global Flupentixol Sale Price by Application (2021-2026) & (US$/kg)
Table 34. Global Flupentixol Sales by Company (2021-2026) & (Ton)
Table 35. Global Flupentixol Sales Market Share by Company (2021-2026)
Table 36. Global Flupentixol Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Flupentixol Revenue Market Share by Company (2021-2026)
Table 38. Global Flupentixol Sale Price by Company (2021-2026) & (US$/kg)
Table 39. Key Manufacturers Flupentixol Producing Area Distribution and Sales Area
Table 40. Players Flupentixol Products Offered
Table 41. Flupentixol Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Flupentixol Sales by Geographic Region (2021-2026) & (Ton)
Table 45. Global Flupentixol Sales Market Share Geographic Region (2021-2026)
Table 46. Global Flupentixol Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Flupentixol Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Flupentixol Sales by Country/Region (2021-2026) & (Ton)
Table 49. Global Flupentixol Sales Market Share by Country/Region (2021-2026)
Table 50. Global Flupentixol Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Flupentixol Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Flupentixol Sales by Country (2021-2026) & (Ton)
Table 53. Americas Flupentixol Sales Market Share by Country (2021-2026)
Table 54. Americas Flupentixol Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Flupentixol Sales by Type (2021-2026) & (Ton)
Table 56. Americas Flupentixol Sales by Application (2021-2026) & (Ton)
Table 57. APAC Flupentixol Sales by Region (2021-2026) & (Ton)
Table 58. APAC Flupentixol Sales Market Share by Region (2021-2026)
Table 59. APAC Flupentixol Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Flupentixol Sales by Type (2021-2026) & (Ton)
Table 61. APAC Flupentixol Sales by Application (2021-2026) & (Ton)
Table 62. Europe Flupentixol Sales by Country (2021-2026) & (Ton)
Table 63. Europe Flupentixol Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Flupentixol Sales by Type (2021-2026) & (Ton)
Table 65. Europe Flupentixol Sales by Application (2021-2026) & (Ton)
Table 66. Middle East & Africa Flupentixol Sales by Country (2021-2026) & (Ton)
Table 67. Middle East & Africa Flupentixol Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Flupentixol Sales by Type (2021-2026) & (Ton)
Table 69. Middle East & Africa Flupentixol Sales by Application (2021-2026) & (Ton)
Table 70. Key Market Drivers & Growth Opportunities of Flupentixol
Table 71. Key Market Challenges & Risks of Flupentixol
Table 72. Key Industry Trends of Flupentixol
Table 73. Flupentixol Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Flupentixol Distributors List
Table 76. Flupentixol Customer List
Table 77. Global Flupentixol Sales Forecast by Region (2027-2032) & (Ton)
Table 78. Global Flupentixol Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Flupentixol Sales Forecast by Country (2027-2032) & (Ton)
Table 80. Americas Flupentixol Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Flupentixol Sales Forecast by Region (2027-2032) & (Ton)
Table 82. APAC Flupentixol Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Flupentixol Sales Forecast by Country (2027-2032) & (Ton)
Table 84. Europe Flupentixol Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Flupentixol Sales Forecast by Country (2027-2032) & (Ton)
Table 86. Middle East & Africa Flupentixol Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Flupentixol Sales Forecast by Type (2027-2032) & (Ton)
Table 88. Global Flupentixol Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Flupentixol Sales Forecast by Application (2027-2032) & (Ton)
Table 90. Global Flupentixol Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Lundbeck Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 92. Lundbeck Flupentixol Product Portfolios and Specifications
Table 93. Lundbeck Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Lundbeck Main Business
Table 95. Lundbeck Latest Developments
Table 96. Sandoz Canada Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 97. Sandoz Canada Flupentixol Product Portfolios and Specifications
Table 98. Sandoz Canada Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Sandoz Canada Main Business
Table 100. Sandoz Canada Latest Developments
Table 101. Global Calcium Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 102. Global Calcium Flupentixol Product Portfolios and Specifications
Table 103. Global Calcium Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Global Calcium Main Business
Table 105. Global Calcium Latest Developments
Table 106. Centaur Pharmaceuticals Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 107. Centaur Pharmaceuticals Flupentixol Product Portfolios and Specifications
Table 108. Centaur Pharmaceuticals Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Centaur Pharmaceuticals Main Business
Table 110. Centaur Pharmaceuticals Latest Developments
Table 111. Pharmaffiliates Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 112. Pharmaffiliates Flupentixol Product Portfolios and Specifications
Table 113. Pharmaffiliates Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Pharmaffiliates Main Business
Table 115. Pharmaffiliates Latest Developments
Table 116. Sun Pharma Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 117. Sun Pharma Flupentixol Product Portfolios and Specifications
Table 118. Sun Pharma Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Sun Pharma Main Business
Table 120. Sun Pharma Latest Developments
Table 121. Haisco Pharmaceutical Group Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 122. Haisco Pharmaceutical Group Flupentixol Product Portfolios and Specifications
Table 123. Haisco Pharmaceutical Group Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Haisco Pharmaceutical Group Main Business
Table 125. Haisco Pharmaceutical Group Latest Developments
Table 126. Chongqing Shenghuaxi Pharmaceutical Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 127. Chongqing Shenghuaxi Pharmaceutical Flupentixol Product Portfolios and Specifications
Table 128. Chongqing Shenghuaxi Pharmaceutical Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Chongqing Shenghuaxi Pharmaceutical Main Business
Table 130. Chongqing Shenghuaxi Pharmaceutical Latest Developments
Table 131. Brilliant Pharmaceuticals Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 132. Brilliant Pharmaceuticals Flupentixol Product Portfolios and Specifications
Table 133. Brilliant Pharmaceuticals Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Brilliant Pharmaceuticals Main Business
Table 135. Brilliant Pharmaceuticals Latest Developments
Table 136. Guangzhou Green Cross Pharmaceutical Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 137. Guangzhou Green Cross Pharmaceutical Flupentixol Product Portfolios and Specifications
Table 138. Guangzhou Green Cross Pharmaceutical Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Guangzhou Green Cross Pharmaceutical Main Business
Table 140. Guangzhou Green Cross Pharmaceutical Latest Developments
Table 141. China Medical System Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 142. China Medical System Flupentixol Product Portfolios and Specifications
Table 143. China Medical System Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. China Medical System Main Business
Table 145. China Medical System Latest Developments
Table 1. Flupentixol Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Flupentixol Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of API (Active Pharmaceutical Ingredient)
Table 4. Major Players ofTablet
Table 5. Major Players of Drops/Oral Solution
Table 6. Major Players of Long-Acting Intramuscular Injection
Table 7. Global Flupentixol Sales by Type (2021-2026) & (Ton)
Table 8. Global Flupentixol Sales Market Share by Type (2021-2026)
Table 9. Global Flupentixol Revenue by Type (2021-2026) & ($ million)
Table 10. Global Flupentixol Revenue Market Share by Type (2021-2026)
Table 11. Global Flupentixol Sale Price by Type (2021-2026) & (US$/kg)
Table 12. Major Players of Flupentixol Base
Table 13. Major Players of Flupentixol Dihydrochloride
Table 14. Major Players of Flupentixol Decanoate
Table 15. Global Flupentixol Sales by Chemical Form (2021-2026) & (Ton)
Table 16. Global Flupentixol Sales Market Share by Chemical Form (2021-2026)
Table 17. Global Flupentixol Revenue by Chemical Form (2021-2026) & ($ million)
Table 18. Global Flupentixol Revenue Market Share by Chemical Form (2021-2026)
Table 19. Global Flupentixol Sale Price by Chemical Form (2021-2026) & (US$/kg)
Table 20. Major Players of Schizophrenia
Table 21. Major Players of Chronic Psychosis
Table 22. Major Players of Anxiety/Depression
Table 23. Major Players of Regional/Localized Psychosis
Table 24. Global Flupentixol Sales by Target Condition (2021-2026) & (Ton)
Table 25. Global Flupentixol Sales Market Share by Target Condition (2021-2026)
Table 26. Global Flupentixol Revenue by Target Condition (2021-2026) & ($ million)
Table 27. Global Flupentixol Revenue Market Share by Target Condition (2021-2026)
Table 28. Global Flupentixol Sale Price by Target Condition (2021-2026) & (US$/kg)
Table 29. Global Flupentixol Sale by Application (2021-2026) & (Ton)
Table 30. Global Flupentixol Sale Market Share by Application (2021-2026)
Table 31. Global Flupentixol Revenue by Application (2021-2026) & ($ million)
Table 32. Global Flupentixol Revenue Market Share by Application (2021-2026)
Table 33. Global Flupentixol Sale Price by Application (2021-2026) & (US$/kg)
Table 34. Global Flupentixol Sales by Company (2021-2026) & (Ton)
Table 35. Global Flupentixol Sales Market Share by Company (2021-2026)
Table 36. Global Flupentixol Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Flupentixol Revenue Market Share by Company (2021-2026)
Table 38. Global Flupentixol Sale Price by Company (2021-2026) & (US$/kg)
Table 39. Key Manufacturers Flupentixol Producing Area Distribution and Sales Area
Table 40. Players Flupentixol Products Offered
Table 41. Flupentixol Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Flupentixol Sales by Geographic Region (2021-2026) & (Ton)
Table 45. Global Flupentixol Sales Market Share Geographic Region (2021-2026)
Table 46. Global Flupentixol Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Flupentixol Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Flupentixol Sales by Country/Region (2021-2026) & (Ton)
Table 49. Global Flupentixol Sales Market Share by Country/Region (2021-2026)
Table 50. Global Flupentixol Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Flupentixol Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Flupentixol Sales by Country (2021-2026) & (Ton)
Table 53. Americas Flupentixol Sales Market Share by Country (2021-2026)
Table 54. Americas Flupentixol Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Flupentixol Sales by Type (2021-2026) & (Ton)
Table 56. Americas Flupentixol Sales by Application (2021-2026) & (Ton)
Table 57. APAC Flupentixol Sales by Region (2021-2026) & (Ton)
Table 58. APAC Flupentixol Sales Market Share by Region (2021-2026)
Table 59. APAC Flupentixol Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Flupentixol Sales by Type (2021-2026) & (Ton)
Table 61. APAC Flupentixol Sales by Application (2021-2026) & (Ton)
Table 62. Europe Flupentixol Sales by Country (2021-2026) & (Ton)
Table 63. Europe Flupentixol Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Flupentixol Sales by Type (2021-2026) & (Ton)
Table 65. Europe Flupentixol Sales by Application (2021-2026) & (Ton)
Table 66. Middle East & Africa Flupentixol Sales by Country (2021-2026) & (Ton)
Table 67. Middle East & Africa Flupentixol Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Flupentixol Sales by Type (2021-2026) & (Ton)
Table 69. Middle East & Africa Flupentixol Sales by Application (2021-2026) & (Ton)
Table 70. Key Market Drivers & Growth Opportunities of Flupentixol
Table 71. Key Market Challenges & Risks of Flupentixol
Table 72. Key Industry Trends of Flupentixol
Table 73. Flupentixol Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Flupentixol Distributors List
Table 76. Flupentixol Customer List
Table 77. Global Flupentixol Sales Forecast by Region (2027-2032) & (Ton)
Table 78. Global Flupentixol Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Flupentixol Sales Forecast by Country (2027-2032) & (Ton)
Table 80. Americas Flupentixol Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Flupentixol Sales Forecast by Region (2027-2032) & (Ton)
Table 82. APAC Flupentixol Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Flupentixol Sales Forecast by Country (2027-2032) & (Ton)
Table 84. Europe Flupentixol Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Flupentixol Sales Forecast by Country (2027-2032) & (Ton)
Table 86. Middle East & Africa Flupentixol Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Flupentixol Sales Forecast by Type (2027-2032) & (Ton)
Table 88. Global Flupentixol Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Flupentixol Sales Forecast by Application (2027-2032) & (Ton)
Table 90. Global Flupentixol Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Lundbeck Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 92. Lundbeck Flupentixol Product Portfolios and Specifications
Table 93. Lundbeck Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Lundbeck Main Business
Table 95. Lundbeck Latest Developments
Table 96. Sandoz Canada Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 97. Sandoz Canada Flupentixol Product Portfolios and Specifications
Table 98. Sandoz Canada Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Sandoz Canada Main Business
Table 100. Sandoz Canada Latest Developments
Table 101. Global Calcium Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 102. Global Calcium Flupentixol Product Portfolios and Specifications
Table 103. Global Calcium Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Global Calcium Main Business
Table 105. Global Calcium Latest Developments
Table 106. Centaur Pharmaceuticals Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 107. Centaur Pharmaceuticals Flupentixol Product Portfolios and Specifications
Table 108. Centaur Pharmaceuticals Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Centaur Pharmaceuticals Main Business
Table 110. Centaur Pharmaceuticals Latest Developments
Table 111. Pharmaffiliates Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 112. Pharmaffiliates Flupentixol Product Portfolios and Specifications
Table 113. Pharmaffiliates Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Pharmaffiliates Main Business
Table 115. Pharmaffiliates Latest Developments
Table 116. Sun Pharma Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 117. Sun Pharma Flupentixol Product Portfolios and Specifications
Table 118. Sun Pharma Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Sun Pharma Main Business
Table 120. Sun Pharma Latest Developments
Table 121. Haisco Pharmaceutical Group Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 122. Haisco Pharmaceutical Group Flupentixol Product Portfolios and Specifications
Table 123. Haisco Pharmaceutical Group Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Haisco Pharmaceutical Group Main Business
Table 125. Haisco Pharmaceutical Group Latest Developments
Table 126. Chongqing Shenghuaxi Pharmaceutical Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 127. Chongqing Shenghuaxi Pharmaceutical Flupentixol Product Portfolios and Specifications
Table 128. Chongqing Shenghuaxi Pharmaceutical Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Chongqing Shenghuaxi Pharmaceutical Main Business
Table 130. Chongqing Shenghuaxi Pharmaceutical Latest Developments
Table 131. Brilliant Pharmaceuticals Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 132. Brilliant Pharmaceuticals Flupentixol Product Portfolios and Specifications
Table 133. Brilliant Pharmaceuticals Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Brilliant Pharmaceuticals Main Business
Table 135. Brilliant Pharmaceuticals Latest Developments
Table 136. Guangzhou Green Cross Pharmaceutical Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 137. Guangzhou Green Cross Pharmaceutical Flupentixol Product Portfolios and Specifications
Table 138. Guangzhou Green Cross Pharmaceutical Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Guangzhou Green Cross Pharmaceutical Main Business
Table 140. Guangzhou Green Cross Pharmaceutical Latest Developments
Table 141. China Medical System Basic Information, Flupentixol Manufacturing Base, Sales Area and Its Competitors
Table 142. China Medical System Flupentixol Product Portfolios and Specifications
Table 143. China Medical System Flupentixol Sales (Ton), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. China Medical System Main Business
Table 145. China Medical System Latest Developments
LIST OF FIGURES
Figure 1. Picture of Flupentixol
Figure 2. Flupentixol Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flupentixol Sales Growth Rate 2021-2032 (Ton)
Figure 7. Global Flupentixol Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Flupentixol Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Flupentixol Sales Market Share by Country/Region (2025)
Figure 10. Flupentixol Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of API (Active Pharmaceutical Ingredient)
Figure 12. Product Picture ofTablet
Figure 13. Product Picture of Drops/Oral Solution
Figure 14. Product Picture of Long-Acting Intramuscular Injection
Figure 15. Global Flupentixol Sales Market Share by Type in 2026
Figure 16. Global Flupentixol Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Flupentixol Base
Figure 18. Product Picture of Flupentixol Dihydrochloride
Figure 19. Product Picture of Flupentixol Decanoate
Figure 20. Global Flupentixol Sales Market Share by Chemical Form in 2026
Figure 21. Global Flupentixol Revenue Market Share by Chemical Form (2021-2026)
Figure 22. Product Picture of Schizophrenia
Figure 23. Product Picture of Chronic Psychosis
Figure 24. Product Picture of Anxiety/Depression
Figure 25. Product Picture of Regional/Localized Psychosis
Figure 26. Global Flupentixol Sales Market Share by Target Condition in 2026
Figure 27. Global Flupentixol Revenue Market Share by Target Condition (2021-2026)
Figure 28. Flupentixol Consumed in Hospital Psychiatric Department
Figure 29. Global Flupentixol Market: Hospital Psychiatric Department (2021-2026) & (Ton)
Figure 30. Flupentixol Consumed in Specialist Clinic
Figure 31. Global Flupentixol Market: Specialist Clinic (2021-2026) & (Ton)
Figure 32. Flupentixol Consumed in Retail Pharmacie
Figure 33. Global Flupentixol Market: Retail Pharmacie (2021-2026) & (Ton)
Figure 34. Flupentixol Consumed in Others
Figure 35. Global Flupentixol Market: Others (2021-2026) & (Ton)
Figure 36. Global Flupentixol Sale Market Share by Application (2025)
Figure 37. Global Flupentixol Revenue Market Share by Application in 2025
Figure 38. Flupentixol Sales by Company in 2025 (Ton)
Figure 39. Global Flupentixol Sales Market Share by Company in 2025
Figure 40. Flupentixol Revenue by Company in 2025 ($ millions)
Figure 41. Global Flupentixol Revenue Market Share by Company in 2025
Figure 42. Global Flupentixol Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Flupentixol Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Flupentixol Sales 2021-2026 (Ton)
Figure 45. Americas Flupentixol Revenue 2021-2026 ($ millions)
Figure 46. APAC Flupentixol Sales 2021-2026 (Ton)
Figure 47. APAC Flupentixol Revenue 2021-2026 ($ millions)
Figure 48. Europe Flupentixol Sales 2021-2026 (Ton)
Figure 49. Europe Flupentixol Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Flupentixol Sales 2021-2026 (Ton)
Figure 51. Middle East & Africa Flupentixol Revenue 2021-2026 ($ millions)
Figure 52. Americas Flupentixol Sales Market Share by Country in 2025
Figure 53. Americas Flupentixol Revenue Market Share by Country (2021-2026)
Figure 54. Americas Flupentixol Sales Market Share by Type (2021-2026)
Figure 55. Americas Flupentixol Sales Market Share by Application (2021-2026)
Figure 56. United States Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Flupentixol Sales Market Share by Region in 2025
Figure 61. APAC Flupentixol Revenue Market Share by Region (2021-2026)
Figure 62. APAC Flupentixol Sales Market Share by Type (2021-2026)
Figure 63. APAC Flupentixol Sales Market Share by Application (2021-2026)
Figure 64. China Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 68. India Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Flupentixol Sales Market Share by Country in 2025
Figure 72. Europe Flupentixol Revenue Market Share by Country (2021-2026)
Figure 73. Europe Flupentixol Sales Market Share by Type (2021-2026)
Figure 74. Europe Flupentixol Sales Market Share by Application (2021-2026)
Figure 75. Germany Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 76. France Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Flupentixol Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Flupentixol Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Flupentixol Sales Market Share by Application (2021-2026)
Figure 83. Egypt Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Flupentixol in 2026
Figure 89. Manufacturing Process Analysis of Flupentixol
Figure 90. Industry Chain Structure of Flupentixol
Figure 91. Channels of Distribution
Figure 92. Global Flupentixol Sales Market Forecast by Region (2027-2032)
Figure 93. Global Flupentixol Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Flupentixol Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Flupentixol Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Flupentixol Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Flupentixol Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Flupentixol
Figure 2. Flupentixol Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flupentixol Sales Growth Rate 2021-2032 (Ton)
Figure 7. Global Flupentixol Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Flupentixol Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Flupentixol Sales Market Share by Country/Region (2025)
Figure 10. Flupentixol Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of API (Active Pharmaceutical Ingredient)
Figure 12. Product Picture ofTablet
Figure 13. Product Picture of Drops/Oral Solution
Figure 14. Product Picture of Long-Acting Intramuscular Injection
Figure 15. Global Flupentixol Sales Market Share by Type in 2026
Figure 16. Global Flupentixol Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Flupentixol Base
Figure 18. Product Picture of Flupentixol Dihydrochloride
Figure 19. Product Picture of Flupentixol Decanoate
Figure 20. Global Flupentixol Sales Market Share by Chemical Form in 2026
Figure 21. Global Flupentixol Revenue Market Share by Chemical Form (2021-2026)
Figure 22. Product Picture of Schizophrenia
Figure 23. Product Picture of Chronic Psychosis
Figure 24. Product Picture of Anxiety/Depression
Figure 25. Product Picture of Regional/Localized Psychosis
Figure 26. Global Flupentixol Sales Market Share by Target Condition in 2026
Figure 27. Global Flupentixol Revenue Market Share by Target Condition (2021-2026)
Figure 28. Flupentixol Consumed in Hospital Psychiatric Department
Figure 29. Global Flupentixol Market: Hospital Psychiatric Department (2021-2026) & (Ton)
Figure 30. Flupentixol Consumed in Specialist Clinic
Figure 31. Global Flupentixol Market: Specialist Clinic (2021-2026) & (Ton)
Figure 32. Flupentixol Consumed in Retail Pharmacie
Figure 33. Global Flupentixol Market: Retail Pharmacie (2021-2026) & (Ton)
Figure 34. Flupentixol Consumed in Others
Figure 35. Global Flupentixol Market: Others (2021-2026) & (Ton)
Figure 36. Global Flupentixol Sale Market Share by Application (2025)
Figure 37. Global Flupentixol Revenue Market Share by Application in 2025
Figure 38. Flupentixol Sales by Company in 2025 (Ton)
Figure 39. Global Flupentixol Sales Market Share by Company in 2025
Figure 40. Flupentixol Revenue by Company in 2025 ($ millions)
Figure 41. Global Flupentixol Revenue Market Share by Company in 2025
Figure 42. Global Flupentixol Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Flupentixol Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Flupentixol Sales 2021-2026 (Ton)
Figure 45. Americas Flupentixol Revenue 2021-2026 ($ millions)
Figure 46. APAC Flupentixol Sales 2021-2026 (Ton)
Figure 47. APAC Flupentixol Revenue 2021-2026 ($ millions)
Figure 48. Europe Flupentixol Sales 2021-2026 (Ton)
Figure 49. Europe Flupentixol Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Flupentixol Sales 2021-2026 (Ton)
Figure 51. Middle East & Africa Flupentixol Revenue 2021-2026 ($ millions)
Figure 52. Americas Flupentixol Sales Market Share by Country in 2025
Figure 53. Americas Flupentixol Revenue Market Share by Country (2021-2026)
Figure 54. Americas Flupentixol Sales Market Share by Type (2021-2026)
Figure 55. Americas Flupentixol Sales Market Share by Application (2021-2026)
Figure 56. United States Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Flupentixol Sales Market Share by Region in 2025
Figure 61. APAC Flupentixol Revenue Market Share by Region (2021-2026)
Figure 62. APAC Flupentixol Sales Market Share by Type (2021-2026)
Figure 63. APAC Flupentixol Sales Market Share by Application (2021-2026)
Figure 64. China Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 68. India Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Flupentixol Sales Market Share by Country in 2025
Figure 72. Europe Flupentixol Revenue Market Share by Country (2021-2026)
Figure 73. Europe Flupentixol Sales Market Share by Type (2021-2026)
Figure 74. Europe Flupentixol Sales Market Share by Application (2021-2026)
Figure 75. Germany Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 76. France Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Flupentixol Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Flupentixol Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Flupentixol Sales Market Share by Application (2021-2026)
Figure 83. Egypt Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Flupentixol Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Flupentixol in 2026
Figure 89. Manufacturing Process Analysis of Flupentixol
Figure 90. Industry Chain Structure of Flupentixol
Figure 91. Channels of Distribution
Figure 92. Global Flupentixol Sales Market Forecast by Region (2027-2032)
Figure 93. Global Flupentixol Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Flupentixol Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Flupentixol Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Flupentixol Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Flupentixol Revenue Market Share Forecast by Application (2027-2032)
